Nathan D. Jorgensen Voyager Therapeutics, Inc. (VYGR) insider trading activity

Nathan D. Jorgensen is Chief Financial Officer of Voyager Therapeutics, Inc.. Currently has a direct ownership of 131,500 shares of VYGR, which is worth approximately $510,220. The most recent transaction as insider was on Feb 21, 2025, when has been sold 51,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

64.38% 3M change

n/a 12M change

Total Value Held $510,220

Nathan D. Jorgensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 21 2025	BUY Grant, award, or other acquisition	-	51,500 Added 28.14%	131,500 Common Stock
Oct 01 2024	BUY Grant, award, or other acquisition	-	80,000 Added 50.0%	80,000 Common Stock

Also insider at

VOR

Vor Biopharma Inc. Healthcare

CHIEF FINANCIAL OFFICER

NDJ